Serum IP-10 levels and increased DPPIV activity are linked to circulating CXCR3+ T cells in cholestatic HCV patients
Monika Rau(LMU Klinikum), Andreas Geier(Swiss Integrative Center for Human Health)
Cited by 6
Related Papers
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling
|Journal of Hepatology|2023|92
Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management
|Liver Cancer|2023|44